SE414403B - Forfarande for framstellning av kinazolinonderivat - Google Patents
Forfarande for framstellning av kinazolinonderivatInfo
- Publication number
- SE414403B SE414403B SE7506140A SE7506140A SE414403B SE 414403 B SE414403 B SE 414403B SE 7506140 A SE7506140 A SE 7506140A SE 7506140 A SE7506140 A SE 7506140A SE 414403 B SE414403 B SE 414403B
- Authority
- SE
- Sweden
- Prior art keywords
- group
- quinazolinone
- phenyl
- alkyl group
- nitro
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 12
- -1 tetrahydrofurfuryl group Chemical group 0.000 claims description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 6
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 6
- 229910052753 mercury Inorganic materials 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- AVRPFRMDMNDIDH-UHFFFAOYSA-N 1h-quinazolin-2-one Chemical class C1=CC=CC2=NC(O)=NC=C21 AVRPFRMDMNDIDH-UHFFFAOYSA-N 0.000 claims description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- NTURVSFTOYPGON-UHFFFAOYSA-N Dihydroquinazoline Chemical class C1=CC=C2C=NCNC2=C1 NTURVSFTOYPGON-UHFFFAOYSA-N 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 claims 1
- 125000006173 tetrahydropyranylmethyl group Chemical group 0.000 claims 1
- 125000005301 thienylmethyl group Chemical group [H]C1=C([H])C([H])=C(S1)C([H])([H])* 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
- CTOUNZIAEBIWAW-UHFFFAOYSA-N 3,4-dihydro-1h-quinazolin-2-one Chemical class C1=CC=C2NC(=O)NCC2=C1 CTOUNZIAEBIWAW-UHFFFAOYSA-N 0.000 description 4
- IXVBNJRBXHFFPQ-UHFFFAOYSA-N 6-chloro-1-(cyclopropylmethyl)-4-phenylquinazolin-2-one Chemical compound O=C1N=C(C=2C=CC=CC=2)C2=CC(Cl)=CC=C2N1CC1CC1 IXVBNJRBXHFFPQ-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000012286 potassium permanganate Substances 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- QEJDKDAVMNFUCI-UHFFFAOYSA-N 1-(cyclohexylmethyl)-6-nitro-4-phenylquinazolin-2-one Chemical compound O=C1N=C(C=2C=CC=CC=2)C2=CC([N+](=O)[O-])=CC=C2N1CC1CCCCC1 QEJDKDAVMNFUCI-UHFFFAOYSA-N 0.000 description 1
- JLZJFNPVVSIUAJ-UHFFFAOYSA-N 1-(cyclopentylmethyl)-6-nitro-4-phenylquinazolin-2-one Chemical compound O=C1N=C(C=2C=CC=CC=2)C2=CC([N+](=O)[O-])=CC=C2N1CC1CCCC1 JLZJFNPVVSIUAJ-UHFFFAOYSA-N 0.000 description 1
- JISZFLNTQKRDRD-UHFFFAOYSA-N 1-(cyclopropylmethyl)-6-methylsulfanyl-4-phenylquinazolin-2-one Chemical compound O=C1N=C(C=2C=CC=CC=2)C2=CC(SC)=CC=C2N1CC1CC1 JISZFLNTQKRDRD-UHFFFAOYSA-N 0.000 description 1
- OSCJNCWKJPGCKI-UHFFFAOYSA-N 1-(cyclopropylmethyl)-6-methylsulfonyl-4-phenylquinazolin-2-one Chemical compound O=C1N=C(C=2C=CC=CC=2)C2=CC(S(=O)(=O)C)=CC=C2N1CC1CC1 OSCJNCWKJPGCKI-UHFFFAOYSA-N 0.000 description 1
- XWWYZFUBBJHKSP-UHFFFAOYSA-N 2,3-dihydro-1h-quinazolin-4-one Chemical compound C1=CC=C2C(=O)NCNC2=C1 XWWYZFUBBJHKSP-UHFFFAOYSA-N 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 1
- FHUBTSLLILWICW-UHFFFAOYSA-N 4-phenyl-1h-quinazolin-2-one Chemical compound C12=CC=CC=C2NC(=O)N=C1C1=CC=CC=C1 FHUBTSLLILWICW-UHFFFAOYSA-N 0.000 description 1
- GKSMPQBWGVIPAR-UHFFFAOYSA-N 6,8-dichloro-1-(cyclopropylmethyl)-4-phenylquinazolin-2-one Chemical compound O=C1N=C(C=2C=CC=CC=2)C2=CC(Cl)=CC(Cl)=C2N1CC1CC1 GKSMPQBWGVIPAR-UHFFFAOYSA-N 0.000 description 1
- QXYUYUVMXHBCAX-UHFFFAOYSA-N 6-nitro-1-(oxan-2-ylmethyl)-4-phenylquinazolin-2-one Chemical compound O=C1N=C(C=2C=CC=CC=2)C2=CC([N+](=O)[O-])=CC=C2N1CC1CCCCO1 QXYUYUVMXHBCAX-UHFFFAOYSA-N 0.000 description 1
- WJXFXVTYWJNFFA-UHFFFAOYSA-N 6-nitro-4-phenyl-1-(pyridin-2-ylmethyl)quinazolin-2-one Chemical compound O=C1N=C(C=2C=CC=CC=2)C2=CC([N+](=O)[O-])=CC=C2N1CC1=CC=CC=N1 WJXFXVTYWJNFFA-UHFFFAOYSA-N 0.000 description 1
- XTIZUTQBXFZEAW-UHFFFAOYSA-N 6-nitro-4-phenyl-1-(thiophen-2-ylmethyl)quinazolin-2-one Chemical compound O=C1N=C(C=2C=CC=CC=2)C2=CC([N+](=O)[O-])=CC=C2N1CC1=CC=CS1 XTIZUTQBXFZEAW-UHFFFAOYSA-N 0.000 description 1
- OQBDAQQKVBUXKR-UHFFFAOYSA-N 6-nitro-4-phenyl-1h-quinazolin-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)N=C1C1=CC=CC=C1 OQBDAQQKVBUXKR-UHFFFAOYSA-N 0.000 description 1
- 101100298295 Drosophila melanogaster flfl gene Proteins 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
- C07D239/82—Oxygen atoms with an aryl radical attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP49061684A JPS5919098B2 (ja) | 1974-05-30 | 1974-05-30 | キナゾリン誘導体の製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7506140L SE7506140L (sv) | 1975-12-01 |
| SE414403B true SE414403B (sv) | 1980-07-28 |
Family
ID=13178325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7506140A SE414403B (sv) | 1974-05-30 | 1975-05-29 | Forfarande for framstellning av kinazolinonderivat |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPS5919098B2 (de) |
| AT (1) | AT346335B (de) |
| CA (1) | CA1047967A (de) |
| CH (1) | CH599172A5 (de) |
| NL (1) | NL7506338A (de) |
| SE (1) | SE414403B (de) |
-
1974
- 1974-05-30 JP JP49061684A patent/JPS5919098B2/ja not_active Expired
-
1975
- 1975-05-28 AT AT408875A patent/AT346335B/de not_active IP Right Cessation
- 1975-05-29 SE SE7506140A patent/SE414403B/sv unknown
- 1975-05-29 CA CA228,044A patent/CA1047967A/en not_active Expired
- 1975-05-29 NL NL7506338A patent/NL7506338A/xx not_active Application Discontinuation
- 1975-05-30 CH CH702675A patent/CH599172A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AT346335B (de) | 1978-11-10 |
| CH599172A5 (en) | 1978-05-12 |
| JPS50151887A (de) | 1975-12-06 |
| NL7506338A (nl) | 1975-12-02 |
| SE7506140L (sv) | 1975-12-01 |
| JPS5919098B2 (ja) | 1984-05-02 |
| CA1047967A (en) | 1979-02-06 |
| ATA408875A (de) | 1978-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105283442B (zh) | 用于合成1‑(2‑((2,4‑二甲基苯基)硫代)苯基)哌嗪的方法 | |
| CN111635387B (zh) | 一种色原酮衍生物的合成方法 | |
| SE414403B (sv) | Forfarande for framstellning av kinazolinonderivat | |
| US4021469A (en) | Process for preparing N-phenylcarbamates | |
| CN107722101A (zh) | 甾体吡啶类衍生物及其制备方法和应用 | |
| Omar et al. | Studies on 4-thiazolidinones. IX. The conversion of 5-substituted 2-thioxo-4-thiazolidinones into corresponding 2, 4-thiazolidinediones. | |
| SE421005B (sv) | Triepoxiandrostanderivat till anvendning som utgangsmaterial for framstellning av kurareaktigt verkande steroidforeningar och forfarande for framstellning derav | |
| JP2719841B2 (ja) | チオ尿素誘導体及びその製造方法 | |
| NO159905B (no) | Herdbar bindemiddelblanding for formbare stoepeblandinger. | |
| JPS59206350A (ja) | １−置換アゼチジン−３−オ−ル誘導体の製造 | |
| SU1168554A1 (ru) | Способ получени 5,6-замещенных 3,4-дициано-2( @ ) пиридонов | |
| CA1108623A (en) | Isatin process and products | |
| JPH061776A (ja) | 置換ピラジンカルボニトリルの製造方法 | |
| CH657860A5 (it) | Procedimento per la preparazione di derivati 16alpha-idrossi-17alpha-aminopregnanici. | |
| PT96250A (pt) | Processo para a preparacao de derivados da rifamicina | |
| Pifferi et al. | 2, 3-Benzoxazines. IX. Synthesis and central nervous system depressant activity of some 3, 6-and 3, 7-disubstituted 1H-3, 4-dihydro-2, 3-benzoxazines | |
| May | 3, 4-Dihydro-1, 3-oxazines from Dcycloheexylcarbodiimide | |
| Tran et al. | Base‐Promoted Construction of Benzo [4, 5] imidazo [1, 2‐c][1, 3] thiazinethiones via C− N/C− S Cyclization | |
| JPH10251259A (ja) | １，４，６，９−テトラアザ−５，１０−デヒドロフェナジン誘導体及びその製造法 | |
| RU2339623C1 (ru) | Способ получения нитропроизводных 2-галоген-9,10-дигидро-9-акридинонов из 5-галоген-3-арил-2,1-бензизоксазолов | |
| Fridecky et al. | Poly-L-α, γ-diaminobutyric Acid Hydrochloride | |
| KR960003319B1 (ko) | 신규한 엔(n)-아릴설포닐-2-이미다졸리디논 유도체 및 그의 제조방법 | |
| JPS5862168A (ja) | テトラゾ−ル誘導体 | |
| JPH013187A (ja) | ピラゾロ〔１，５−ａ〕−１，３，５−ベンゾトリアゼピン系化合物 | |
| JPS6213953B2 (de) |